Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Center Evaluates Outcomes of Florida Pill Mill Laws and Prescription Drug Monitoring
  • USA - English


News provided by

JoTo PR

Oct 19, 2015, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

New Port Richey, FL (PRWEB) October 19, 2015 -- A new study published this month revealed that Florida’s prescription drug monitoring program (PDMP) and pill mill laws have contributed to decreases in opioid prescriptions and abuse (1), reflecting similar findings published by federal and state agencies. Novus Medical Detox Center—a leading Florida-based drug treatment facility—analyzes the outcomes of these efforts, including how they might be implemented in other states and how they have affected illicit drug use overall.

These outcomes illustrate the dramatic impact Florida’s prescription drug monitoring program and tougher laws have had on rogue pill mills, prescription opioid abuse and overdose deaths.

Post this

Florida was once considered the “epicenter of the nation’s ‘pill mill’ epidemic” (2) due to “weak regulatory oversights” and the absence of a statewide PDMP (3). In 2010, the DEA reported that 90 of the nation’s top 100 oxycodone-purchasing physicians were located in Florida (2), which was also home to more than 900 pain management clinics (3). That same year, Florida recorded 2,722 overdose deaths from prescription drugs, including 2,560 from opioid analgesics and a record 1,516 from oxycodone alone (4).

In 2011, state officials and legislators took action to combat prescription drug abuse and rising overdose deaths, implementing a statewide PDMP and enacting stricter laws to regulate pain clinics (5). As a result of these measures:

• Within the first year of implementation, Florida’s PDMP and pill mill laws led to statistically significant decreases in opioid prescriptions, opioid volume and morphine milligram equivalent per transaction (1).
• Oxycodone purchases by Florida doctors decreased 97% in 2011 compared to the previous year (4).
• By 2011, only 13 of the nation’s top 100 oxycodone-dispensing prescribers remained in Florida; as of 2013, there were none (4).
• In 2014, just 367 pain management clinics were registered in Florida (3).
• From December 2011 to September 2014, “doctor shopping”—obtaining prescriptions from more than five doctors and five pharmacies—declined 53% in Florida, from 2,864 to 1,355 cases (5).
• In 2012, Florida prescription overdose deaths fell to 2,116 and opioid analgesic deaths to 1,892; compared to 2010, those figures dropped by 22.3% and 26.1%, respectively (4).
• Oxycodone overdose deaths have steadily declined, from 1,247 in 2011, to 735 in 2012, to 534 in 2013—a 65% decrease over 2010 rates (5).

“These outcomes illustrate the dramatic impact Florida’s prescription drug monitoring program and tougher laws have had on rogue pill mills, prescription opioid abuse and overdose deaths,” said Kent Runyon, Executive Director of Novus Medical Detox Center. “Other states would be wise to follow Florida’s approach in targeting prescription drug abuse, since pain clinics will set up shop wherever there are lax laws and weak regulatory oversight.”

Following Florida’s pill mill crackdown, pain clinic operators moved to neighboring Georgia. By 2011, over one-fifth of the top 100 oxycodone-purchasing physicians were located in Georgia (2). While the state had just 10 pain clinics in 2010, there were up to 140 just three years later—leading Georgia to implement its own PDMP and pill mill laws (6).

Runyon advocates for strict pain clinic laws and PDMPs in every state, but cautions that opioid users often transition to more readily available street drugs if they can’t obtain prescription analgesics. In Florida, heroin overdose deaths jumped from 48 to 108 between 2010 and 2012—a 125% increase (4). “To prevent drug switching and minimize illicit drug use overall, it’s critical to provide existing opioid abusers with access to detox and drug rehab programs,” Runyon concluded.

Novus offers medically supervised opiate and opioid treatment programs—from oxycodone detox to heroin withdrawal—that employ proven medical protocols and cutting-edge detox technology. The Florida-based drug treatment facility provides individually customized treatment programs with 24/7 access to nursing care and withdrawal specialists for an easier detox and a successful recovery.

To learn more about Novus Medical Detox Center and its opiate/opioid treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:

Novus Medical Detox Center is a Joint Commission Accredited inpatient medical detox facility. Novus offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Florida, Novus is also licensed by the Florida Department of Children and Families and is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient. By incorporating medication, natural supplements and fluid replenishment, Novus tailors the detox process for each patient, putting the dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, cable television and high-speed Internet access. Novus’ expansion is tied to their contribution to their industry and their local community, ranking number 48 on the Tampa Bay Business Journal’s 2014 Fast 50 Awards list of the fastest-growing companies in Tampa Bay, and number 2,936 on the 2014 Inc. 500/5000 list of fastest-growing companies in America. For more information, visit http://www.novusdetox.com.

1. Rutkow, Lainie; Hsien-Yen Chang; et al. “Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use”; JAMA Internal Medicine; October 2015. archinte.jamanetwork.com/article.aspx?articleid=2429105

2. U.S. Drug Enforcement Administration (DEA). “Florida Law Enforcement Prescription Drug Efforts Produce Positive Results”; DEA press release; January 30, 2012. dea.gov/divisions/mia/2012/mia013012p.html

3. Office of the Attorney General of Florida. “Pill Mill Initiative”; accessed October 14, 2015. myfloridalegal.com/pages.nsf/Main/AA7AAF5CAA22638D8525791B006A30C8

4. U.S. Centers for Disease Control and Prevention. Decline in Drug Overdose Deaths After State Policy Changes — Florida, 2010–2012; July 4, 2014. cdc.gov/mmwr/preview/mmwrhtml/mm6326a3.htm

5. Florida Department of Health. E-FORCSE: 2013-2014 Prescription Drug Monitoring Program Annual Report; December 1, 2014. floridahealth.gov/statistics-and-data/e-forcse/news-reports/2014-pdmp-annual-report-final.pdf

6. Brumback, Kate. “Georgia Lawmakers OK Crackdown on So-Called Pill Mills”; The Washington Examiner; March 21, 2013. washingtonexaminer.com/georgia-lawmakers-ok-crackdown-on-so-called-pill-mills/article/2525076/comments

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.